Exelixis, Inc.EXELNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P0
Near historical low
vs 3Y Ago
-1.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q1 2026-100.00%
Q4 2025-0.59%
Q3 2025-5.60%
Q2 2025-14.77%
Q4 202411.88%
Q3 20245.41%
Q2 2024-7.27%
Q1 2024-6.94%
Q4 2023-26.43%
Q3 202343.00%
Q2 2023-0.72%
Q1 2023-30.45%
Q4 202269.40%
Q3 2022-0.32%
Q3 202227.32%
Q2 2022-29.51%
Q4 202136.05%
Q4 20219.80%
Q3 2021-6.59%
Q2 20213.25%
Q4 2020-12.72%
Q4 202053.80%
Q3 202012.82%
Q2 20207.87%
Q4 2019-2.93%
Q3 201918.75%
Q2 201929.46%
Q1 201910.51%
Q4 201828.01%
Q3 20185.30%
Q2 201812.53%
Q1 201817.24%
Q4 201712.83%
Q3 20171.17%
Q2 201721.56%
Q1 2017-2.48%
Q4 201617.50%
Q3 2016-11.87%
Q3 2016-20.54%
Q2 201623.24%